2017
DOI: 10.1200/edbk_175444
|View full text |Cite
|
Sign up to set email alerts
|

Health Disparities and the Global Landscape of Lymphoma Care Today

Abstract: Lymphoma encompass a wide variety of distinct disease entities, including, but not limited to, subtypes of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). In the last 3 decades, therapeutic advancements have resulted in substantial improvements in lymphoma outcome. In most high-income regions, HL is a largely curable disease and for patients with two frequent subtypes of NHL, diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), survival has dramatically improved with the incorporation of r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 73 publications
0
9
0
Order By: Relevance
“…Likewise, the Korea Central Cancer Registry (KCCR) and the Korean Society of Hematology (KSH) jointly investigated the domestic prevalence and incidence rates of hematologic malignancies since 1999 and analyzed survival rates of patients [5,6]. Different incidence rates and trends have been reported for specific subtypes of lymphomas among regions, and some discriminative features were reported in the Asian population in the United States or Europe [7]. For example, decreased incidence rate in the Asian population for overall lymphoid malignancies was observed, which was prominent for follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), and Hodgkin lymphoma (HL).…”
Section: Introductionmentioning
confidence: 99%
“…Likewise, the Korea Central Cancer Registry (KCCR) and the Korean Society of Hematology (KSH) jointly investigated the domestic prevalence and incidence rates of hematologic malignancies since 1999 and analyzed survival rates of patients [5,6]. Different incidence rates and trends have been reported for specific subtypes of lymphomas among regions, and some discriminative features were reported in the Asian population in the United States or Europe [7]. For example, decreased incidence rate in the Asian population for overall lymphoid malignancies was observed, which was prominent for follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), and Hodgkin lymphoma (HL).…”
Section: Introductionmentioning
confidence: 99%
“…They also had worse lactate dehydrogenase (LDH), B-symptoms and Eastern Cooperative Oncology Group (ECOG) status, when compared to white population. The difference in outcome can be attributed to the biological factors related to the tumor, healthcare services utilization, and the socioeconomic differences among different ethnic groups [ 12 - 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Guidelines informed by these principles will differ from those in high-income countries, but they will prove to be more effective in LMICs. 34,40…”
Section: Discussionmentioning
confidence: 99%